Literature DB >> 21530648

Ubiquitin-proteasome pathway and cellular responses to oxidative stress.

Fu Shang1, Allen Taylor.   

Abstract

The ubiquitin-proteasome pathway (UPP) is the primary cytosolic proteolytic machinery for the selective degradation of various forms of damaged proteins. Thus, the UPP is an important protein quality control mechanism. In the canonical UPP, both ubiquitin and the 26S proteasome are involved. Substrate proteins of the canonical UPP are first tagged by multiple ubiquitin molecules and then degraded by the 26S proteasome. However, in noncanonical UPP, proteins can be degraded by the 26S or the 20S proteasome without being ubiquitinated. It is clear that a proteasome is responsible for selective degradation of oxidized proteins, but the extent to which ubiquitination is involved in this process remains a subject of debate. Whereas many publications suggest that the 20S proteasome degrades oxidized proteins independent of ubiquitin, there is also solid evidence indicating that ubiquitin and ubiquitination are involved in degradation of some forms of oxidized proteins. A fully functional UPP is required for cells to cope with oxidative stress and the activity of the UPP is also modulated by cellular redox status. Mild or transient oxidative stress up-regulates the ubiquitination system and proteasome activity in cells and tissues and transiently enhances intracellular proteolysis. Severe or sustained oxidative stress impairs the function of the UPP and decreases intracellular proteolysis. Both the ubiquitin-conjugating enzymes and the proteasome can be inactivated by sustained oxidative stress, especially the 26S proteasome. Differential susceptibilities of the ubiquitin-conjugating enzymes and the 26S proteasome to oxidative damage lead to an accumulation of ubiquitin conjugates in cells in response to mild oxidative stress. Thus, increased levels of ubiquitin conjugates in cells seem to be an indicator of mild oxidative stress.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21530648      PMCID: PMC3109097          DOI: 10.1016/j.freeradbiomed.2011.03.031

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  223 in total

1.  A proteasomal ATPase subunit recognizes the polyubiquitin degradation signal.

Authors:  Y Amy Lam; T Glen Lawson; Murugesan Velayutham; Jay L Zweier; Cecile M Pickart
Journal:  Nature       Date:  2002-04-18       Impact factor: 49.962

Review 2.  Protein degradation and protection against misfolded or damaged proteins.

Authors:  Alfred L Goldberg
Journal:  Nature       Date:  2003-12-18       Impact factor: 49.962

3.  Proteasomal inhibition causes the formation of protein aggregates containing a wide range of proteins, including nitrated proteins.

Authors:  Dong-Hoon Hyun; MoonHee Lee; Barry Halliwell; Peter Jenner
Journal:  J Neurochem       Date:  2003-07       Impact factor: 5.372

4.  A proteasomal stress response: pre-treatment with proteasome inhibitors increases proteasome activity and reduces neuronal vulnerability to oxidative injury.

Authors:  Chul-Sang Lee; Lee Y Tee; Timothy Warmke; Anant Vinjamoori; Aili Cai; Anne M Fagan; B Joy Snider
Journal:  J Neurochem       Date:  2004-11       Impact factor: 5.372

5.  Nontoxic proteasome inhibition activates a protective antioxidant defense response in endothelial cells.

Authors:  Silke Meiners; Antje Ludwig; Mario Lorenz; Henryk Dreger; Gert Baumann; Verena Stangl; Karl Stangl
Journal:  Free Radic Biol Med       Date:  2006-03-31       Impact factor: 7.376

Review 6.  Degradation of oxidized proteins in mammalian cells.

Authors:  T Grune; T Reinheckel; K J Davies
Journal:  FASEB J       Date:  1997-06       Impact factor: 5.191

7.  Loss of Usp14 results in reduced levels of ubiquitin in ataxia mice.

Authors:  Christopher Anderson; Stephen Crimmins; Julie A Wilson; Greg A Korbel; Hidde L Ploegh; Scott M Wilson
Journal:  J Neurochem       Date:  2005-09-29       Impact factor: 5.372

8.  Simultaneous inhibition of hsp 90 and the proteasome promotes protein ubiquitination, causes endoplasmic reticulum-derived cytosolic vacuolization, and enhances antitumor activity.

Authors:  Edward G Mimnaugh; Wanping Xu; Michele Vos; Xitong Yuan; Jennifer S Isaacs; Kheem S Bisht; David Gius; Len Neckers
Journal:  Mol Cancer Ther       Date:  2004-05       Impact factor: 6.261

9.  Aging and proteolysis of oxidized proteins.

Authors:  S Agarwal; R S Sohal
Journal:  Arch Biochem Biophys       Date:  1994-02-15       Impact factor: 4.013

10.  Enhancement of proteasome activity by a small-molecule inhibitor of USP14.

Authors:  Byung-Hoon Lee; Min Jae Lee; Soyeon Park; Dong-Chan Oh; Suzanne Elsasser; Ping-Chung Chen; Carlos Gartner; Nevena Dimova; John Hanna; Steven P Gygi; Scott M Wilson; Randall W King; Daniel Finley
Journal:  Nature       Date:  2010-09-09       Impact factor: 49.962

View more
  140 in total

1.  Redox control of 20S proteasome gating.

Authors:  Gustavo M Silva; Luis E S Netto; Vanessa Simões; Luiz F A Santos; Fabio C Gozzo; Marcos A A Demasi; Cristiano L P Oliveira; Renata N Bicev; Clécio F Klitzke; Mari C Sogayar; Marilene Demasi
Journal:  Antioxid Redox Signal       Date:  2012-03-06       Impact factor: 8.401

Review 2.  Roles for the ubiquitin-proteasome pathway in protein quality control and signaling in the retina: implications in the pathogenesis of age-related macular degeneration.

Authors:  Fu Shang; Allen Taylor
Journal:  Mol Aspects Med       Date:  2012-04-10

3.  Glycation-altered proteolysis as a pathobiologic mechanism that links dietary glycemic index, aging, and age-related disease (in nondiabetics).

Authors:  Tomoaki Uchiki; Karen A Weikel; Wangwang Jiao; Fu Shang; Andrea Caceres; Dorota Pawlak; James T Handa; Michael Brownlee; Ram Nagaraj; Allen Taylor
Journal:  Aging Cell       Date:  2011-11-15       Impact factor: 9.304

4.  Increased mammalian lifespan and a segmental and tissue-specific slowing of aging after genetic reduction of mTOR expression.

Authors:  J Julie Wu; Jie Liu; Edmund B Chen; Jennifer J Wang; Liu Cao; Nisha Narayan; Marie M Fergusson; Ilsa I Rovira; Michele Allen; Danielle A Springer; Cory U Lago; Shuling Zhang; Wendy DuBois; Theresa Ward; Rafael deCabo; Oksana Gavrilova; Beverly Mock; Toren Finkel
Journal:  Cell Rep       Date:  2013-08-29       Impact factor: 9.423

5.  Differential Response to High Glucose in Skin Fibroblasts of Monozygotic Twins Discordant for Type 1 Diabetes.

Authors:  M Luiza Caramori; Youngki Kim; Rama Natarajan; Jason H Moore; Stephen S Rich; Josyf C Mychaleckyj; Ryoko Kuriyama; David Kirkpatrick; Michael Mauer
Journal:  J Clin Endocrinol Metab       Date:  2015-04-22       Impact factor: 5.958

Review 6.  Clearance of Amyloid Beta and Tau in Alzheimer's Disease: from Mechanisms to Therapy.

Authors:  Shu-Hui Xin; Lin Tan; Xipeng Cao; Jin-Tai Yu; Lan Tan
Journal:  Neurotox Res       Date:  2018-04-07       Impact factor: 3.911

7.  Measuring redox effects on the activities of intracellular proteases such as the 20S Proteasome and the Immuno-Proteasome with fluorogenic peptides.

Authors:  Vicent Bonet-Costa; Patrick Y Sun; Kelvin J A Davies
Journal:  Free Radic Biol Med       Date:  2019-07-25       Impact factor: 7.376

8.  Oligomerization with wt αA- and αB-crystallins reduces proteasome-mediated degradation of C-terminally truncated αA-crystallin.

Authors:  Mingxing Wu; Xinyu Zhang; Qingning Bian; Allen Taylor; Jack J Liang; Linlin Ding; Joseph Horwitz; Fu Shang
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-05-04       Impact factor: 4.799

9.  Differential correlations between changes to glutathione redox state, protein ubiquitination, and stress-inducible HSPA chaperone expression after different types of oxidative stress.

Authors:  Pierre-Marie Girard; Nathalie Peynot; Jean-Marc Lelièvre
Journal:  Cell Stress Chaperones       Date:  2018-05-12       Impact factor: 3.667

10.  miR-100 antagonism triggers apoptosis by inhibiting ubiquitination-mediated p53 degradation.

Authors:  G Yang; Y Gong; Q Wang; L Wang; X Zhang
Journal:  Oncogene       Date:  2016-08-15       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.